| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Fernando Silva Ramalho | Q39743324 |
| P2093 | author name string | Deisy Mara da Silva | |
| Leandra Naira Z Ramalho | |||
| Marlei Josiele Augusto | |||
| Sheila Cristina L Sanches | |||
| P2860 | cites work | A collaborative database of inbred mouse strain characteristics. | Q50874227 |
| Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. | Q51353878 | ||
| Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis | Q57760188 | ||
| Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients | Q57760193 | ||
| Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis | Q73735584 | ||
| Lessons from animal models of NASH | Q81296801 | ||
| COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator | Q82931755 | ||
| High-fat emulsion-induced rat model of nonalcoholic steatohepatitis | Q83176488 | ||
| Misuse of scoring systems | Q83846265 | ||
| Editorial: Exploring Lipid-related Treatment Options for the Treatment of NASH | Q85887107 | ||
| Fructose consumption as a risk factor for non-alcoholic fatty liver disease | Q24657933 | ||
| Modulation of hepatic steatosis by dietary fatty acids | Q26991735 | ||
| Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Q27006131 | ||
| Effects of a post-weaning cafeteria diet in young rats: metabolic syndrome, reduced activity and low anxiety-like behaviour | Q28538837 | ||
| Nonalcoholic fatty liver disease | Q29619354 | ||
| Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet | Q30399845 | ||
| Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation | Q33755829 | ||
| Genetic control of de novo lipogenesis: role in diet-induced obesity | Q33867059 | ||
| Experimental models of non-alcoholic fatty liver disease in rats | Q33886936 | ||
| High fat diet feeding results in gender specific steatohepatitis and inflammasome activation | Q33887008 | ||
| Leptin | Q33904994 | ||
| A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits | Q33947195 | ||
| High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis | Q34023013 | ||
| Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease | Q34069352 | ||
| Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. | Q34234946 | ||
| A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain | Q34305197 | ||
| Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants | Q34893236 | ||
| Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy | Q35210714 | ||
| Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition | Q35562084 | ||
| Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. | Q35781449 | ||
| Cell death and cell death responses in liver disease: mechanisms and clinical relevance | Q35938040 | ||
| Review article: steatosis, the metabolic syndrome and cancer | Q36286303 | ||
| Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. | Q36377266 | ||
| Fructose: a key factor in the development of metabolic syndrome and hypertension | Q36916094 | ||
| The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. | Q37061247 | ||
| A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin | Q37122485 | ||
| Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis | Q37299002 | ||
| Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive | Q37310296 | ||
| Nonalcoholic fatty liver disease and cardiovascular risk | Q37318761 | ||
| Reproductive function of the male obese Zucker rats: alteration in sperm production and sperm DNA damage | Q37430152 | ||
| The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet | Q37709683 | ||
| The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome | Q37724585 | ||
| Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease. | Q37748674 | ||
| Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites | Q37777696 | ||
| Animal models of nonalcoholic fatty liver disease | Q37814048 | ||
| Cell death and nonalcoholic steatohepatitis: where is ballooning relevant? | Q37863134 | ||
| Animal models for the study of hepatic fibrosis | Q37865871 | ||
| Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis | Q37953770 | ||
| Murine models for pharmacological studies of the metabolic syndrome | Q38062299 | ||
| Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse. | Q38290875 | ||
| Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis | Q38303488 | ||
| Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis | Q38310080 | ||
| Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver | Q38326652 | ||
| Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin | Q38338847 | ||
| In vitro and in vivo protection of stellate cells from apoptosis by leptin | Q39213616 | ||
| Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle | Q40721809 | ||
| Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent | Q40762653 | ||
| Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model | Q41761778 | ||
| Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats | Q41854395 | ||
| High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase | Q41856930 | ||
| Cyclooxygenase-2 promotes hepatocellular apoptosis by interacting with TNF-α and IL-6 in the pathogenesis of nonalcoholic steatohepatitis in rats | Q42249904 | ||
| Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis | Q43174499 | ||
| Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis | Q43292661 | ||
| Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis | Q44624724 | ||
| Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice | Q45059652 | ||
| A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats | Q45136902 | ||
| Cafeteria diet induces obesity and insulin resistance associated with oxidative stress but not with inflammation: improvement by dietary supplementation with a melon superoxide dismutase | Q45190002 | ||
| Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. | Q45917922 | ||
| Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. | Q46117666 | ||
| Steatohepatitis induced by intragastric overfeeding in mice | Q46320547 | ||
| MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes | Q46555840 | ||
| Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. | Q46955928 | ||
| Model of nonalcoholic steatohepatitis | Q48034818 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| steatohepatitis | Q2335423 | ||
| liver cirrhosis | Q147778 | ||
| animal disease model | Q64732998 | ||
| biomedical investigative technique | Q66648976 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 574832 | |
| P577 | publication date | 2015-05-03 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Nonalcoholic Steatohepatitis: A Search for Factual Animal Models | |
| P478 | volume | 2015 |
| Q92466268 | A Microphysiological System for Studying Nonalcoholic Steatohepatitis |
| Q38858268 | A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer |
| Q91894702 | A new method to induce nonalcoholic steatohepatitis (NASH) in mice |
| Q41761865 | A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis |
| Q92466276 | Ablation of Hmgb1 in Intestinal Epithelial Cells Causes Intestinal Lipid Accumulation and Reduces NASH in Mice |
| Q36071135 | An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis |
| Q38849996 | An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present |
| Q39018492 | An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors |
| Q47106480 | Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide |
| Q64248823 | Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress |
| Q50951548 | Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men. |
| Q38291587 | Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice |
| Q39109576 | Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis |
| Q42355577 | ER Stress-induced Inflammasome Activation Contributes to Hepatic Inflammation and Steatosis |
| Q41692185 | Enhanced Steatosis and Fibrosis in Liver of Adult Offspring Exposed to Maternal High-Fat Diet |
| Q36159376 | Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice |
| Q38998070 | Fatty liver promotes fibrosis in monkeys consuming high fructose |
| Q28074455 | How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease? |
| Q58700518 | Human hepatic 3D spheroids as a model for steatosis and insulin resistance |
| Q33678636 | Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol. |
| Q38790566 | Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver disease |
| Q37575895 | Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway |
| Q58795421 | LncRNA-AK012226 Is Involved in Fat Accumulation in db/db Mice Fatty Liver and Non-alcoholic Fatty Liver Disease Cell Model |
| Q51673296 | MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters. |
| Q91782011 | MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice |
| Q61443044 | Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes |
| Q48318207 | Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats |
| Q89220189 | Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease |
| Q89108940 | Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research |
| Q58103241 | Mouse models of nonalcoholic steatohepatitis Towards optimization of their relevance to human NASH |
| Q58764790 | Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization |
| Q58111297 | Nicotinic alpha 7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis |
| Q46251147 | Non-alcoholic fatty liver disease (NAFLD) models in drug discovery |
| Q39333577 | Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century |
| Q92154626 | Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy |
| Q36796030 | Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance |
| Q46292627 | Nonhuman Primates and Translational Research-Cardiovascular Disease. |
| Q37008626 | Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy. |
| Q64087904 | Pathogenesis of and major animal models used for nonalcoholic fatty liver disease |
| Q47806979 | Pepsin egg white hydrolysate ameliorates metabolic syndrome in high-fat/high-dextrose fed rats |
| Q64964830 | Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats. |
| Q64253375 | Rapid Recapitulation of Nonalcoholic Steatohepatitis upon Loss of Host Cell Factor 1 Function in Mouse Hepatocytes |
| Q55312591 | Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report. |
| Q90398912 | Spectrofluorometric Analysis of Autofluorescing Components of Crude Serum from a Rat Liver Model of Ischemia and Reperfusion |
| Q64078618 | The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose |
| Q48326227 | The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis |
| Q40216300 | The differential effects of low birth weight and Western diet consumption upon early life hepatic fibrosis development in guinea pig. |
| Q48304990 | The hepatoprotective effect of Phyllanthus emblica L. fruit on high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats. |
| Q39140524 | Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease |
| Q37381302 | Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver disease. |
| Q40154406 | Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β. |
| Q47721272 | Updates on Dietary Models of Non-Alcoholic Fatty Liver Disease: Current Studies and Insights |
| Q39639230 | n-3 Fatty acids modulate the mRNA expression of the Nlrp3 inflammasome and Mtor in the liver of rats fed with high-fat or high-fat/fructose diets |
Search more.